1
|
Fardella E, Zanirato G, Magni M, Caldarelli N, Chiappella A, Dodero A, Ljevar S, Orsucci L, Re A, Usai SV, Stefoni V, Castellino C, Rossi FG, Pinto A, Carniti C, Corradini P. Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas. Br J Haematol 2024. [PMID: 38176400 DOI: 10.1111/bjh.19280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 12/14/2023] [Accepted: 12/19/2023] [Indexed: 01/06/2024]
Abstract
Peripheral T-cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell-free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre-treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression-free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre-treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.
Collapse
Affiliation(s)
| | - G Zanirato
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - M Magni
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | | | - A Chiappella
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - A Dodero
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S Ljevar
- Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | - L Orsucci
- Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Turin, Italy
| | - A Re
- Hematology Division, ASST Spedali Civili di Brescia, Brescia, Italy
| | - S V Usai
- Hematology Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy
| | - V Stefoni
- Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy
| | - C Castellino
- Division of Hematology, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
| | - F G Rossi
- Division of Hematology, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy
| | - A Pinto
- Hematology-Oncology & Stem Cell Transplantation Unit, IRCCS Istituto Nazionale Tumori, Fondazione G. Pascale, Napoli, Italy
| | - C Carniti
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - P Corradini
- University of Milan, Milan, Italy
- Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| |
Collapse
|
2
|
Abstract
Summary Background. Kounis syndrome (KS) is defined as a rare cause of an acute coronary syndrome associated with systemic allergic reactions. To establish the prevalence of KS among the patients with diagnosis of anaphylaxis, we described clinical features, cardiological and allergological outcomes of patients evaluated in our allergy outpatient clinic. Methods. A retrospective study was carried out in the Allergy Unit of Novara hospital, from January 2008 to March 2020. Skin tests and in vitro tests were performed with suspected etiological agents. Results. We found 9 adults with KS (2%) out of 444 subjects who had experienced anaphylactic reactions (4/9 to Hymenoptera stings, 5/9 to drugs). Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.
Collapse
Affiliation(s)
- G Zisa
- Allergy Unit, Department of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - A Panero
- Department of Medicine, Hospital of Biella, Biella, Italy
| | - A Re
- Department of Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - M G Mennuni
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
| | - G Patti
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - M Pirisi
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
- Division of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| |
Collapse
|
3
|
Antonicelli G, Ricci L, Tarraran L, Fraterrigo Garofalo S, Re A, Vasile NS, Verga F, Pirri CF, Menin B, Agostino V. Expanding the product portfolio of carbon dioxide and hydrogen-based gas fermentation with an evolved strain of Clostridium carboxidivorans. Bioresour Technol 2023; 387:129689. [PMID: 37597573 DOI: 10.1016/j.biortech.2023.129689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 08/09/2023] [Accepted: 08/15/2023] [Indexed: 08/21/2023]
Abstract
CO2:H2-based gas fermentation with acetogenic Clostridium species are at an early stage of development. This work exploited the Adaptive Laboratory Evolution technique to improve the growth of C. carboxidivorans P7 on CO2 and H2. An adapted strain with decreased growth lag phase and improved biomass production was obtained. Genomic analysis revealed a conserved frameshift mutation in the catalytic subunit of the hexameric hydrogenase gene. The resulted truncated protein variant, most likely lacking its functionality, suggests that other hydrogenases might be more efficient for H2-based growth of this strain. Furthermore, the adapted strain generated hexanol as primary fermentation product. For the first time, hexanol was produced directly from CO2:H2 blend, achieving the highest maximum productivity reported so far via gas fermentation. Traces of valerate, pentanol, eptanol and octanol were observed in the fermentation broth. The adapted strain shows promising to enrich the product spectrum targetable by future gas fermentation processes.
Collapse
Affiliation(s)
- G Antonicelli
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - L Ricci
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy
| | - L Tarraran
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - S Fraterrigo Garofalo
- Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - A Re
- Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - N S Vasile
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - F Verga
- Department of Environment, Land and Infrastructure Engineering, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - C F Pirri
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Department of Applied Science and Technology, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Turin, Italy
| | - B Menin
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy; Istituto di Biologia e Biotecnologia Agraria, Consiglio Nazionale delle Ricerche, Via Alfonso Corti 12, 20133 Milan, Italy
| | - V Agostino
- Centre for Sustainable Future Technologies, Fondazione Istituto Italiano di Tecnologia, Via Livorno 60, 10144 Turin, Italy.
| |
Collapse
|
4
|
Li Puma DD, Colussi C, Bandiera B, Puliatti G, Rinaudo M, Cocco S, Paciello F, Re A, Ripoli C, De Chiara G, Bertozzi A, Palamara AT, Piacentini R, Grassi C. Interleukin 1β triggers synaptic and memory deficits in Herpes simplex virus type-1-infected mice by downregulating the expression of synaptic plasticity-related genes via the epigenetic MeCP2/HDAC4 complex. Cell Mol Life Sci 2023; 80:172. [PMID: 37261502 DOI: 10.1007/s00018-023-04817-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Revised: 05/17/2023] [Accepted: 05/20/2023] [Indexed: 06/02/2023]
Abstract
Extensive research provides evidence that neuroinflammation underlies numerous brain disorders. However, the molecular mechanisms by which inflammatory mediators determine synaptic and cognitive dysfunction occurring in neurodegenerative diseases (e.g., Alzheimer's disease) are far from being fully understood. Here we investigated the role of interleukin 1β (IL-1β), and the molecular cascade downstream the activation of its receptor, to the synaptic dysfunction occurring in the mouse model of multiple Herpes simplex virus type-1 (HSV-1) reactivations within the brain. These mice are characterized by neuroinflammation and memory deficits associated with a progressive accumulation of neurodegenerative hallmarks (e.g., amyloid-β protein and tau hyperphosphorylation). Here we show that mice undergone two HSV-1 reactivations in the brain exhibited increased levels of IL-1β along with significant alterations of: (1) cognitive performances; (2) hippocampal long-term potentiation; (3) expression synaptic-related genes and pre- and post-synaptic proteins; (4) dendritic spine density and morphology. These effects correlated with activation of the epigenetic repressor MeCP2 that, in association with HDAC4, affected the expression of synaptic plasticity-related genes. Specifically, in response to HSV-1 infection, HDAC4 accumulated in the nucleus and promoted MeCP2 SUMOylation that is a post-translational modification critically affecting the repressive activity of MeCP2. The blockade of IL-1 receptors by the specific antagonist Anakinra prevented the MeCP2 increase and the consequent downregulation of gene expression along with rescuing structural and functional indices of neurodegeneration. Collectively, our findings provide novel mechanistic evidence on the role played by HSV-1-activated IL-1β signaling pathways in synaptic deficits leading to cognitive impairment.
Collapse
Affiliation(s)
- Domenica Donatella Li Puma
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - Claudia Colussi
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Department of Engineering, Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti", National Research Council, 00185, Rome, Italy
| | - Bruno Bandiera
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - Giulia Puliatti
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - Marco Rinaudo
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - Sara Cocco
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - Fabiola Paciello
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - Agnese Re
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - Cristian Ripoli
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - Giovanna De Chiara
- Institute of Translational Pharmacology, National Research Council (CNR), 00133, Rome, Italy
| | - Alessia Bertozzi
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Department of Engineering, Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti", National Research Council, 00185, Rome, Italy
| | - Anna Teresa Palamara
- Department of Infectious Diseases, Istituto Superiore Di Sanità, 00161, Rome, Italy
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur Italia-Cenci Bolognetti Foundation, 00185, Rome, Italy
| | - Roberto Piacentini
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy.
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy.
| | - Claudio Grassi
- Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| |
Collapse
|
5
|
Mongelli A, Panunzi S, Nesta M, Gottardi Zamperla M, Atlante S, Barbi V, Mongiardini V, Ferraro F, De Martino S, Cis L, Re A, Maltese S, Bachetti T, La Rovere MT, Martelli F, Pesce M, Nanni S, Massetti M, Pontecorvi A, Farsetti A, Gaetano C. Distinguishable DNA methylation defines a cardiac-specific epigenetic clock. Clin Epigenetics 2023; 15:53. [PMID: 36991505 PMCID: PMC10053964 DOI: 10.1186/s13148-023-01467-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2022] [Accepted: 03/18/2023] [Indexed: 03/31/2023] Open
Abstract
BACKGROUND The present study investigates whether epigenetic differences emerge in the heart of patients undergoing cardiac surgery for an aortic valvular replacement (AVR) or coronary artery bypass graft (CABG). An algorithm is also established to determine how the pathophysiological condition might influence the human biological cardiac age. RESULTS Blood samples and cardiac auricles were collected from patients who underwent cardiac procedures: 94 AVR and 289 CABG. The CpGs from three independent blood-derived biological clocks were selected to design a new blood- and the first cardiac-specific clocks. Specifically, 31 CpGs from six age-related genes, ELOVL2, EDARADD, ITGA2B, ASPA, PDE4C, and FHL2, were used to construct the tissue-tailored clocks. The best-fitting variables were combined to define new cardiac- and blood-tailored clocks validated through neural network analysis and elastic regression. In addition, telomere length (TL) was measured by qPCR. These new methods revealed a similarity between chronological and biological age in the blood and heart; the average TL was significantly higher in the heart than in the blood. In addition, the cardiac clock discriminated well between AVR and CABG and was sensitive to cardiovascular risk factors such as obesity and smoking. Moreover, the cardiac-specific clock identified an AVR patient's subgroup whose accelerated bioage correlated with the altered ventricular parameters, including left ventricular diastolic and systolic volume. CONCLUSION This study reports on applying a method to evaluate the cardiac biological age revealing epigenetic features that separate subgroups of AVR and CABG.
Collapse
Affiliation(s)
- A Mongelli
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
- Center for Translational and Experimental Cardiology (CTEC), University of Zurich, 8952, Schlieren, Switzerland
| | - S Panunzi
- National Research Council (CNR)-IASI, 00185, Rome, Italy
| | - M Nesta
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
| | - M Gottardi Zamperla
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - S Atlante
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - V Barbi
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
| | - V Mongiardini
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy
- Molecular Medicine, Istituto Italiano di Tecnologia, Genoa, Italy
| | - F Ferraro
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - S De Martino
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - L Cis
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Re
- National Research Council (CNR)-IASI, 00185, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - S Maltese
- National Research Council (CNR)-IRIB, 90146, Palermo, Italy
| | - T Bachetti
- Direzione Scientifica Centrale ICS Maugeri IRCCS, Pavia, Italy
| | - M T La Rovere
- Dipartimento di Cardiologia ICS Maugeri and Direzione Scientifica ICS Maugeri Montescano IRCCS, Pavia, Italy
| | - F Martelli
- Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy
| | - M Pesce
- Unità di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico Monzino IRCCS, 20138, Milan, Italy
| | - S Nanni
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - M Massetti
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Pontecorvi
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - A Farsetti
- National Research Council (CNR)-IASI, 00185, Rome, Italy.
| | - C Gaetano
- Laboratorio di Epigenetica, Istituti Clinici Scientifici (ICS) Maugeri IRCCS, 27100, Pavia, Italy.
| |
Collapse
|
6
|
Appel S, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Biondi R, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D'Angelo D, Derbin A, Di Giacinto A, Di Marcello V, Ding XF, Di Ludovico A, Di Noto L, Drachnev I, Franco D, Galbiati C, Ghiano C, Giammarchi M, Goretti A, Göttel AS, Gromov M, Guffanti D, Ianni A, Ianni A, Jany A, Kobychev V, Korga G, Kumaran S, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Machulin I, Martyn J, Meroni E, Miramonti L, Misiaszek M, Muratova V, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Pelicci L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli MT, Ranucci G, Razeto A, Re A, Redchuk M, Rossi N, Schönert S, Semenov D, Settanta G, Skorokhvatov M, Singhal A, Smirnov O, Sotnikov A, Tartaglia R, Testera G, Unzhakov E, Villante FL, Vishneva A, Vogelaar RB, von Feilitzsch F, Wojcik M, Wurm M, Zavatarelli S, Zuber K, Zuzel G. Improved Measurement of Solar Neutrinos from the Carbon-Nitrogen-Oxygen Cycle by Borexino and Its Implications for the Standard Solar Model. Phys Rev Lett 2022; 129:252701. [PMID: 36608219 DOI: 10.1103/physrevlett.129.252701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 09/01/2022] [Accepted: 10/05/2022] [Indexed: 06/17/2023]
Abstract
We present an improved measurement of the carbon-nitrogen-oxygen (CNO) solar neutrino interaction rate at Earth obtained with the complete Borexino Phase-III dataset. The measured rate, R_{CNO}=6.7_{-0.8}^{+2.0} counts/(day×100 tonnes), allows us to exclude the absence of the CNO signal with about 7σ C.L. The correspondent CNO neutrino flux is 6.6_{-0.9}^{+2.0}×10^{8} cm^{-2} s^{-1}, taking into account the neutrino flavor conversion. We use the new CNO measurement to evaluate the C and N abundances in the Sun with respect to the H abundance for the first time with solar neutrinos. Our result of N_{CN}=(5.78_{-1.00}^{+1.86})×10^{-4} displays a ∼2σ tension with the "low-metallicity" spectroscopic photospheric measurements. Furthermore, our result used together with the ^{7}Be and ^{8}B solar neutrino fluxes, also measured by Borexino, permits us to disfavor at 3.1σ C.L. the "low-metallicity" standard solar model B16-AGSS09met as an alternative to the "high-metallicity" standard solar model B16-GS98.
Collapse
Affiliation(s)
- S Appel
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - Z Bagdasarian
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - D Basilico
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - G Bellini
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - J Benziger
- Chemical Engineering Department, Princeton University, Princeton, New Jersey 08544, USA
| | - R Biondi
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - B Caccianiga
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - F Calaprice
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Caminata
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - P Cavalcante
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Chepurnov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D D'Angelo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Derbin
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Di Giacinto
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - V Di Marcello
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - X F Ding
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Di Ludovico
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - L Di Noto
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - I Drachnev
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - D Franco
- AstroParticule et Cosmologie, Université Paris Diderot, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, Sorbonne Paris Cité, 75205 Paris Cedex 13, France
| | - C Galbiati
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
- Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - C Ghiano
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - M Giammarchi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Goretti
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A S Göttel
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Gromov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D Guffanti
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - Aldo Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - Andrea Ianni
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Jany
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Kobychev
- Kiev Institute for Nuclear Research, 03680 Kiev, Ukraine
| | - G Korga
- Department of Physics, Royal Holloway University of London, Egham, Surrey,TW20 0EX, United Kingdom
- Institute of Nuclear Research (Atomki), Debrecen, Hungary
| | - S Kumaran
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Laubenstein
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - E Litvinovich
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - P Lombardi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - I Lomskaya
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - L Ludhova
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - G Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - I Machulin
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Martyn
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Meroni
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - L Miramonti
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Misiaszek
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Muratova
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - R Nugmanov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - L Oberauer
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Orekhov
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - F Ortica
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - M Pallavicini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - L Papp
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - L Pelicci
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - Ö Penek
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - L Pietrofaccia
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - N Pilipenko
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Pocar
- Amherst Center for Fundamental Interactions and Physics Department, University of Massachusetts, Amherst, Massachusetts 01003, USA
| | - G Raikov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - M T Ranalli
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - G Ranucci
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Razeto
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - A Re
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Redchuk
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - N Rossi
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - S Schönert
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - D Semenov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - G Settanta
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - M Skorokhvatov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Singhal
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - O Smirnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Sotnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R Tartaglia
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
| | - G Testera
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - E Unzhakov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - F L Villante
- INFN Laboratori Nazionali del Gran Sasso, 67100 Assergi (AQ), Italy
- Dipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, 67100 L'Aquila, Italy
| | - A Vishneva
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R B Vogelaar
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - F von Feilitzsch
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - M Wojcik
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - M Wurm
- Institute of Physics and Excellence Cluster PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Zavatarelli
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - K Zuber
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - G Zuzel
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| |
Collapse
|
7
|
Biamonte F, Re A, Balzamino BO, Ciasca G, Santucci D, Napodano C, Nocca G, Fiorita A, Marino M, Basile U, Micera A, Callà CAM. Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data. J Pers Med 2022; 12:jpm12111877. [PMID: 36579579 PMCID: PMC9697501 DOI: 10.3390/jpm12111877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Revised: 10/24/2022] [Accepted: 11/06/2022] [Indexed: 11/12/2022] Open
Abstract
COVID-19 continues to afflict the global population, causing several pathological diseases and exacerbating co-morbidities due to SARS-CoV-2's high mutation. Recent interest has been devoted to some neuronal manifestations and to increased levels of Nerve Growth Factor (NGF) and Brain-derived Neurotrophic Factor (BDNF) in the bloodstream during SARS-CoV-2 infection, neurotrophins that are well-known for their multifactorial actions on neuro-immune-endocrine and visual functions. Nineteen (19) patients were enrolled in this monocentric prospective study and subjected to anamnesis and biosamples collection (saliva and blood) at hospitalization (acute phase) and 6 months later (remission phase). NGF and BDNF were quantified by ELISA, and biochemical data were related to biostrumental measurements. Increased NGF and BDNF levels were quantified in saliva and serum during the acute phase of SARS-CoV-2 infection (hospitalized patients), and reduced levels were observed in the next 6 months (remission phase), never matching the baseline values. Salivary and circulating data would suggest the possibility of considering sera and saliva as useful matrices for quickly screening neurotrophins, in addition to SARS-CoV2 antigens and RNA. Overall, the findings described herein highlight the importance of NGF and BDNF as dynamic biomarkers for monitoring disease and reinforces the possibility of using saliva and sera for quick, non-invasive COVID-19 screening.
Collapse
Affiliation(s)
- Filippo Biamonte
- Dipartimento di Scienze, Laboratoristiche ed Infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Laboratorio Patologia Clinica, Associazione dei Cavalieri Italiani del Sovrano Militare Ordine di Malta ACISMOM San Giovanni Battista, 00148 Rome, Italy
| | - Agnese Re
- Dipartimento di Scienze, Laboratoristiche ed Infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
| | - Bijorn Omar Balzamino
- Research and Development Laboratory for Biochemical, Molecular and Cellular Applications in Ophthalmological Sciences, Research Laboratories in Ophthalmology, IRCCS-Fondazione Bietti, 00184 Rome, Italy
| | - Gabriele Ciasca
- Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Daniela Santucci
- Center for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, 00161 Rome, Italy
| | - Cecilia Napodano
- Dipartimento di Scienze, Laboratoristiche ed Infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
| | - Giuseppina Nocca
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
- Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Antonella Fiorita
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
- Dipartimento di Scienze dell’Invecchiamento, Neurologiche, Ortopediche e della Testa e del Collo, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Mariapaola Marino
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Umberto Basile
- Dipartimento di Scienze, Laboratoristiche ed Infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
- Correspondence: (U.B.); (A.M.)
| | - Alessandra Micera
- Research and Development Laboratory for Biochemical, Molecular and Cellular Applications in Ophthalmological Sciences, Research Laboratories in Ophthalmology, IRCCS-Fondazione Bietti, 00184 Rome, Italy
- Correspondence: (U.B.); (A.M.)
| | - Cinzia Anna Maria Callà
- Dipartimento di Scienze, Laboratoristiche ed Infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Fondazione Policlinico Universitario “A. Gemelli”, IRCCS, 00168 Rome, Italy
| |
Collapse
|
8
|
Cafiero C, Palmirotta R, Micera A, Ottaiano MP, Re A, Pedata F, Costagliola D, Ponticelli D, Pisconti S, Schiavone B, Benincasa G. SARS-CoV-2 infection after vaccination in Italian health care workers: a case report. Natl Acad Sci Lett 2022; 45:249-254. [PMID: 35283546 PMCID: PMC8898326 DOI: 10.1007/s40009-022-01106-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Revised: 11/27/2021] [Accepted: 01/25/2022] [Indexed: 01/19/2023]
Abstract
Following the approval of COVID-19 vaccination program by EMA and national authorities, an immunization campaign started in Italy with BNT162b2mRNA vaccine, initially focused on healthcare workers. The active immunization was monitored by systemic antibody titration and continuous surveillance was guaranteed by antigenic/molecular tests on swabs. Cases of infection have been recently observed in vaccinated healthcare workers. Herein we describe an outbreak of infection occurring in five physicians out of 656 healthcare workers belonging to a private hospital, referring mild symptoms of COVID-19. Healthcare workers underwent complete vaccination and screening for antibody titration. Five out of 656 healthcare workers were tested positive for SARS-CoV-2 in nasopharyngeal swabs and referred mild COVID-19 symptoms. Molecular analyses were carried out to identify possible variants of Spike protein. Their genotyping performed on RNA extracts highlighted the presence of del69/70, N501Y, A570D, and 1841A > G (D614G) sequence variants, all indicative of VOC 202012/01-lineage B.1.1.7, suggesting a common source of infection. These cases might represent a serious emergency because outbreaks can compromise frail patients with important concomitant diseases.
Collapse
|
9
|
Iezzi M, Cusumano D, Piccari D, Menna S, Catucci F, D'Aviero A, Re A, Di Dio C, Quaranta F, Boschetti A, Marras M, Piro D, Votta C, Sanna E, Flore C, Mattiucci G, Valentini V. PO-1483 A predictive model to quantify the dosimetric impact of inter-fraction variability in breast cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03447-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
10
|
Boschetti A, Votta C, Re A, Piro D, Marras M, D'Aviero A, Catucci F, Cusumano D, Di Dio C, Menna S, Iezzi M, Quaranta F, Flore C, Sanna E, Piccari D, Mattiucci G, Valentini V. PD-0336 Evaluation of a deep-learning segmentation software in thoracic organs at risk: an early analysis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02829-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
11
|
Piro D, Marras M, D'Aviero A, Boschetti A, Votta C, Re A, Catucci F, Cusumano D, Di Dio C, Menna S, Iezzi M, Quaranta F, Flore C, Sanna E, Piccari D, Mattiucci G, Valentini V. PO-1887 Validation of deep learning auto-segmentation in pelvic organs at risk: a preliminary analysis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)03850-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Longo V, Barbati SA, Re A, Paciello F, Bolla M, Rinaudo M, Miraglia F, Alù F, Di Donna MG, Vecchio F, Rossini PM, Podda MV, Grassi C. Transcranial Direct Current Stimulation Enhances Neuroplasticity and Accelerates Motor Recovery in a Stroke Mouse Model. Stroke 2022; 53:1746-1758. [PMID: 35291824 DOI: 10.1161/strokeaha.121.034200] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND More effective strategies are needed to promote poststroke functional recovery. Here, we evaluated the impact of bihemispheric transcranial direct current stimulation (tDCS) on forelimb motor function recovery and the underlying mechanisms in mice subjected to focal ischemia of the motor cortex. METHODS Photothrombotic stroke was induced in the forelimb brain motor area, and tDCS was applied once per day for 3 consecutive days, starting 72 hours after stroke. Grid-walking, single pellet reaching, and grip strength tests were conducted to assess motor function. Local field potentials were recorded to evaluate brain connectivity. Western immunoblotting, ELISA, quantitative real-time polymerase chain reaction, and Golgi-Cox staining were used to uncover tDCS-mediated stroke recovery mechanisms. RESULTS Among our results, tDCS increased the rate of motor recovery, anticipating it at the early subacute stage. In this window, tDCS enhanced BDNF (brain-derived neurotrophic factor) expression and dendritic spine density in the peri-infarct motor cortex, along with increasing functional connectivity between motor and somatosensory cortices. Treatment with the BDNF TrkB (tropomyosin-related tyrosine kinase B) receptor inhibitor, ANA-12, prevented tDCS effects on motor recovery and connectivity as well as the increase of spine density, pERK (phosphorylated extracellular signal-regulated kinase), pCaMKII (phosphorylated calcium/calmodulin-dependent protein kinase II), pMEF (phosphorylated myocyte-enhancer factor), and PSD (postsynaptic density)-95. The tDCS-promoted rescue was paralleled by enhanced plasma BDNF level, suggesting its potential role as circulating prognostic biomarker. CONCLUSIONS The rate of motor recovery is accelerated by tDCS applied in the subacute phase of stroke. Anticipation of motor recovery via vicariate pathways or neural reserve recruitment would potentially enhance the efficacy of standard treatments, such as physical therapy, which is often delayed to a later stage when plastic responses are progressively lower.
Collapse
Affiliation(s)
- Valentina Longo
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Saviana Antonella Barbati
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Agnese Re
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Fabiola Paciello
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Maria Bolla
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Marco Rinaudo
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Francesca Miraglia
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Roma, Italy (F.M., F.A., F.V., P.M.R.)
| | - Francesca Alù
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Roma, Italy (F.M., F.A., F.V., P.M.R.)
| | - Martina Gaia Di Donna
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.)
| | - Fabrizio Vecchio
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Roma, Italy (F.M., F.A., F.V., P.M.R.).,eCampus University, Novedrate, Como, Italy (F.V.)
| | - Paolo Maria Rossini
- Brain Connectivity Laboratory, Department of Neuroscience and Neurorehabilitation, IRCCS San Raffaele Roma, Italy (F.M., F.A., F.V., P.M.R.)
| | - Maria Vittoria Podda
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.).,Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy (M.V.P., C.G.)
| | - Claudio Grassi
- Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy (V.L., S.A.B., A.R., F.P., M.B., M.R., M.G.D.D., M.V.P., C.G.).,Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy (M.V.P., C.G.)
| |
Collapse
|
13
|
Agostini M, Altenmüller K, Appel S, Atroshchenko V, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Biondi R, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D'Angelo D, Davini S, Derbin A, Di Giacinto A, Di Marcello V, Ding XF, Di Ludovico A, Di Noto L, Drachnev I, Formozov A, Franco D, Galbiati C, Ghiano C, Giammarchi M, Goretti A, Göttel AS, Gromov M, Guffanti D, Ianni A, Ianni A, Jany A, Jeschke D, Kobychev V, Korga G, Kumaran S, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Lukyanchenko L, Machulin I, Martyn J, Meroni E, Meyer M, Miramonti L, Misiaszek M, Muratova V, Neumair B, Nieslony M, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Pelicci L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli MT, Ranucci G, Razeto A, Re A, Redchuk M, Romani A, Rossi N, Schönert S, Semenov D, Settanta G, Skorokhvatov M, Singhal A, Smirnov O, Sotnikov A, Suvorov Y, Tartaglia R, Testera G, Thurn J, Unzhakov E, Vishneva A, Vogelaar RB, von Feilitzsch F, Wessel A, Wojcik M, Wonsak B, Wurm M, Zavatarelli S, Zuber K, Zuzel G. First Directional Measurement of Sub-MeV Solar Neutrinos with Borexino. Phys Rev Lett 2022; 128:091803. [PMID: 35302807 DOI: 10.1103/physrevlett.128.091803] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 01/25/2022] [Indexed: 06/14/2023]
Abstract
We report the measurement of sub-MeV solar neutrinos through the use of their associated Cherenkov radiation, performed with the Borexino detector at the Laboratori Nazionali del Gran Sasso. The measurement is achieved using a novel technique that correlates individual photon hits of events to the known position of the Sun. In an energy window between 0.54 to 0.74 MeV, selected using the dominant scintillation light, we have measured 10 887_{-2103}^{+2386}(stat)±947(syst) (68% confidence interval) solar neutrinos out of 19 904 total events. This corresponds to a ^{7}Be neutrino interaction rate of 51.6_{-12.5}^{+13.9} counts/(day·100 ton), which is in agreement with the standard solar model predictions and the previous spectroscopic results of Borexino. The no-neutrino hypothesis can be excluded with >5σ confidence level. For the first time, we have demonstrated the possibility of utilizing the directional Cherenkov information for sub-MeV solar neutrinos, in a large-scale, high light yield liquid scintillator detector. This measurement provides an experimental proof of principle for future hybrid event reconstruction using both Cherenkov and scintillation signatures simultaneously.
Collapse
Affiliation(s)
- M Agostini
- Physik-Department, Technische Universität München, 85748 Garching, Germany
- Department of Physics and Astronomy, University College London, London, WC1E 6BT, United Kingdom
| | - K Altenmüller
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - S Appel
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Atroshchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - Z Bagdasarian
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - D Basilico
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - G Bellini
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - J Benziger
- Chemical Engineering Department, Princeton University, Princeton, New Jersey 08544, USA
| | - R Biondi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - D Bravo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - B Caccianiga
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - F Calaprice
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Caminata
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - P Cavalcante
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - A Chepurnov
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D D'Angelo
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - S Davini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - A Derbin
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Di Giacinto
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - V Di Marcello
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - X F Ding
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Di Ludovico
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - L Di Noto
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - I Drachnev
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Formozov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - D Franco
- APC, Université de Paris, CNRS, Astroparticule et Cosmologie, Paris F-75013, France
| | - C Galbiati
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
- Gran Sasso Science Institute, 67100 L'Aquila, Italy
| | - C Ghiano
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - M Giammarchi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Goretti
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A S Göttel
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Gromov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
- Lomonosov Moscow State University Skobeltsyn Institute of Nuclear Physics, 119234 Moscow, Russia
| | - D Guffanti
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - Aldo Ianni
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - Andrea Ianni
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - A Jany
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - D Jeschke
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Kobychev
- Institute for Nuclear Research of NAS Ukraine, 03028 Kyiv, Ukraine
| | - G Korga
- Department of Physics, School of Engineering, Physical and Mathematical Sciences, Royal Holloway, University of London, Egham, TW20 OEX, United Kingdom
- Institute of Nuclear Research (Atomki), 4026, Debrecen, Hungary
| | - S Kumaran
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Laubenstein
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - E Litvinovich
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - P Lombardi
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - I Lomskaya
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - L Ludhova
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - G Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - L Lukyanchenko
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - I Machulin
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - J Martyn
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - E Meroni
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Meyer
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - L Miramonti
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Misiaszek
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - V Muratova
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - B Neumair
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - M Nieslony
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - R Nugmanov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - L Oberauer
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - V Orekhov
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - F Ortica
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - M Pallavicini
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - L Papp
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - L Pelicci
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - Ö Penek
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - L Pietrofaccia
- Physics Department, Princeton University, Princeton, New Jersey 08544, USA
| | - N Pilipenko
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Pocar
- Amherst Center for Fundamental Interactions and Physics Department, UMass, Amherst, Massachusetts 01003, USA
| | - G Raikov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
| | - M T Ranalli
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - G Ranucci
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - A Razeto
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - A Re
- Dipartimento di Fisica, Università degli Studi e INFN, 20133 Milano, Italy
| | - M Redchuk
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - A Romani
- Dipartimento di Chimica, Biologia e Biotecnologie, Università degli Studi e INFN, 06123 Perugia, Italy
| | - N Rossi
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - S Schönert
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - D Semenov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - G Settanta
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
| | - M Skorokhvatov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia
| | - A Singhal
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - O Smirnov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - A Sotnikov
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - Y Suvorov
- National Research Centre Kurchatov Institute, 123182 Moscow, Russia
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - R Tartaglia
- INFN Laboratori Nazionali del Gran Sasso, 67010 Assergi (AQ), Italy
| | - G Testera
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - J Thurn
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - E Unzhakov
- St. Petersburg Nuclear Physics Institute NRC Kurchatov Institute, 188350 Gatchina, Russia
| | - A Vishneva
- Joint Institute for Nuclear Research, 141980 Dubna, Russia
| | - R B Vogelaar
- Physics Department, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061, USA
| | - F von Feilitzsch
- Physik-Department, Technische Universität München, 85748 Garching, Germany
| | - A Wessel
- GSI Helmholtzzentrum für Schwerionenforschung, Planckstrasse 1, D-64291 Darmstadt, Germany
- Institut für Kernphysik, Forschungszentrum Jülich, 52425 Jülich, Germany
- III. Physikalisches Institut B, RWTH Aachen University, 52062 Aachen, Germany
| | - M Wojcik
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| | - B Wonsak
- University of Hamburg, Institute of Experimental Physics, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - M Wurm
- Institute of Physics and Cluster of Excellence PRISMA+, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany
| | - S Zavatarelli
- Dipartimento di Fisica, Università degli Studi e INFN, 16146 Genova, Italy
| | - K Zuber
- Department of Physics, Technische Universität Dresden, 01062 Dresden, Germany
| | - G Zuzel
- M. Smoluchowski Institute of Physics, Jagiellonian University, 30348 Krakow, Poland
| |
Collapse
|
14
|
Renna P, Ripoli C, Dagliyan O, Pastore F, Rinaudo M, Re A, Paciello F, Grassi C. Engineering a switchable single‐chain
TEV
protease to control protein maturation in living neurons. Bioeng Transl Med 2022; 7:e10292. [PMID: 35600650 PMCID: PMC9115699 DOI: 10.1002/btm2.10292] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2021] [Revised: 11/13/2021] [Accepted: 12/30/2021] [Indexed: 11/18/2022] Open
Abstract
Engineered proteases are promising tools to address physiological and pathophysiological questions as well as to develop new therapeutic approaches. Here we introduce a new genetically encoded engineered single‐chain tobacco etch virus protease, allowing to control proprotein cleavage in different compartments of living mammalian cells. We demonstrated a set of controllable proteolytic effects, including cytosolic protein cleavage, inducible gene expression, and maturation of brain‐derived neurotrophic factor (BDNF) in the secretory pathway thus showing the versatility of this technique. Of note, the secretory pathway exhibits different characteristics from the cytosol and it is difficult to target because inaccessible to some small molecules. We were able to induce ligand‐mediated BDNF maturation and monitor its effects on dendritic spines in hippocampal pyramidal cells and in the mouse brain. This strategy paves the way to dissect proteolytic cleavage product signaling in various processes as well as for future therapeutic applications.
Collapse
Affiliation(s)
- Pietro Renna
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
| | - Cristian Ripoli
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome Italy
| | - Onur Dagliyan
- Department of Neurobiology Harvard Medical School Boston MA USA
| | - Francesco Pastore
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
| | - Marco Rinaudo
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
| | - Agnese Re
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
| | - Fabiola Paciello
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome Italy
| | - Claudio Grassi
- Department of Neuroscience Università Cattolica del Sacro Cuore, 00168 Rome Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome Italy
| |
Collapse
|
15
|
Grippaudo C, D'Apolito I, Cafiero C, Re A, Chiurazzi P, Frazier-Bowers SA. Validating clinical characteristic of primary failure of eruption (PFE) associated with PTH1R variants. Prog Orthod 2021; 22:43. [PMID: 34897565 PMCID: PMC8666410 DOI: 10.1186/s40510-021-00387-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2021] [Accepted: 10/23/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Primary failure of eruption (PFE) is a hereditary condition, and linkage with variants in the PTH1R gene has been demonstrated in many cases. The clinical severity and expression of PFE is variable, and the genotype-phenotype correlation remains elusive. Further, the similarity between some eruption disorders that are not associated with PTH1R alterations is striking. To better understand the genotype-phenotype correlation, we examined the relationship between the eruption phenotype and PTH1R genotype in 44 patients with suspected PFE and 27 unaffected relatives. Sanger sequencing was employed to analyze carefully selected PFE patients. Potential pathogenicity of variants was evaluated against multiple genetic databases for function prediction and frequency information. RESULTS Mutational analysis of the PTH1R coding sequence revealed 14 different variants in 38 individuals (30 patients and 8 first-degree relatives), 9 exonic and 5 intronic. Their pathogenicity has been reported and compared with the number and severity of clinical signs. In 72.7% of patients with pathogenic variants, five clinical and radiographic criteria have been found: involvement of posterior teeth, involvement of the distal teeth to the most mesial affected, supracrestal presentation, altered vertical growth of the alveolar process and posterior open-bite. In cases with mixed dentition (3), the deciduous molars of the affected quadrant were infraoccluded. DISCUSSION The probability of an affected patient having a PTH1R variant is greater when five specific clinical characteristics are present. The likelihood of an eruption defect in the absence of specific clinical characteristics is rarely associated with a PTH1R mutation. CONCLUSIONS We report here that systematic clinical and radiographic observation using a diagnostic rubric is highly valuable in confirming PFE and offers a reliable alternative for accurate diagnosis.
Collapse
Affiliation(s)
- Cristina Grippaudo
- School of Dentistry, Università Cattolica del Sacro Cuore, L.go Agostino Gemelli 8, 00168, Rome, Italy.,Fondazione Policlinico Universitario "A. Gemelli" IRCCS, L.go Agostino Gemelli 8, 00168, Rome, Italy
| | - Isabella D'Apolito
- School of Dentistry, Università Cattolica del Sacro Cuore, L.go Agostino Gemelli 8, 00168, Rome, Italy
| | | | - Agnese Re
- Università Cattolica del Sacro Cuore, 00168, Rome, Italy
| | - Pietro Chiurazzi
- Dipartimento Universitario Scienze della Vita e Sanità Pubblica, Sezione di Medicina Genomica, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168, Rome, Italy. .,UOC Genetica Medica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
| | | |
Collapse
|
16
|
Cafiero C, Micera A, Re A, Postiglione L, Cacciamani A, Schiavone B, Benincasa G, Palmirotta R. Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection? Curr Genomics 2021; 22:557-563. [PMID: 35382352 PMCID: PMC8922328 DOI: 10.2174/1389202923666211221111527] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Revised: 10/30/2021] [Accepted: 12/08/2021] [Indexed: 11/22/2022] Open
Abstract
:
SARS-CoV-2 pathogenesis has been recently extended to human central nervous system (CNS), in addition to nasopharyngeal truck, eye, lung and gut. The recent literature highlights that some SARS-CoV-2 spike glycoprotein regions homologous to neurotoxin-like peptides might bind to human nicotinic Acetyl-Choline Receptors (nAChRs). Spike-nAChR interaction can probably cause dysregulation of CNS and cholinergic anti-inflammatory pathways and uncontrolled immune-response, both associated to a severe COVID-19 pathophysiology. Herein, we hypothesize that inside the Open Reading Frame (ORF) region of spike glycoprotein, the RNA polymerase can translate small neurotoxic peptides by means of a “jumping mechanism” already demonstrated in other coronaviruses. These small peptides can bind the snAChRs instead of Spike glycoproteins. A striking homology occurred between these small peptides observed by sequence retrieval and proteins alignment. Acting as nAChRs antagonists, these small peptides (conotoxins) could be the explanation for the extrapulmonary clinical manifestations (neurological, hemorrhagic and thrombotic expressions, the prolonged apnea, the cardiocirculatory collapse, the heart arrhythmias, the ventricular tachycardia, the body temperature alteration, the electrolyte K+ imbalance and finally the significant reduction of butyryl cholinesterase (BuChE) plasma levels, as observed in COVID-19 patients. Several factors might induce the expression of these small peptides, including microbiota. The main hypothesis regarding the presence of these small peptides opens a new scenario on the etiology of COVID-19 clinical symptoms observed so far, including the neurological manifestations.
Collapse
Affiliation(s)
| | - Alessandra Micera
- Research Laboratories in Ophthalmology, IRCCS — Fondazione Bietti, Rome,Italy
| | - Agnese Re
- Department of Chemistry and Clinical Biochemistry, Catholic University of Sacred Heart, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome,Italy
| | - Loredana Postiglione
- Department of Translational Medical Sciences, University of Federico II, Naples,Italy
| | - Andrea Cacciamani
- Research Laboratories in Ophthalmology, IRCCS — Fondazione Bietti, Rome,Italy
| | | | - Giulio Benincasa
- Department of Clinical Pathology and Molecular Biology, Pineta Grande Hospital, Castel Volturno, (CE),Italy
| | - Raffaele Palmirotta
- Interdisciplinary Department of Medicine, University of Bari ‘Aldo Moro’, School of Medicine,Italy
| |
Collapse
|
17
|
Cattaneo C, Cancelli V, Imberti L, Dobbs K, Sottini A, Pagani C, Belotti A, Re A, Anastasia A, Quaresima V, Tucci A, Chiorini JA, Su HC, Cohen JI, Burbelo PD, Rossi G, Notarangelo LD. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab. Blood Cancer J 2021; 11:151. [PMID: 34521813 PMCID: PMC8438656 DOI: 10.1038/s41408-021-00546-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 08/14/2021] [Accepted: 08/27/2021] [Indexed: 12/17/2022] Open
Abstract
The ability of patients with hematologic malignancies (HM) to develop an effective humoral immune response after COVID-19 is unknown. A prospective study was performed to monitor the immune response to SARS-CoV-2 of patients with follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), chronic lymphoproliferative disorders (CLD), multiple myeloma (MM), or myelodysplastic/myeloproliferative syndromes (MDS/MPN). Antibody (Ab) levels to the SARS-CoV-2 nucleocapsid (N) and spike (S) protein were measured at +1, +3, +6 months after nasal swabs became PCR-negative. Forty-five patients (9 FL, 8 DLBCL, 8 CLD, 10 MM, 10 MDS/MPS) and 18 controls were studied. Mean anti-N and anti-S-Ab levels were similar between HM patients and controls, and shared the same behavior, with anti-N Ab levels declining at +6 months and anti-S-Ab remaining stable. Seroconversion rates were lower in HM patients than in controls. In lymphoma patients mean Ab levels and seroconversion rates were lower than in other HM patients, primarily because all nine patients who had received rituximab within 6 months before COVID-19 failed to produce anti-N and anti-S-Ab. Only one patient requiring hematological treatment after COVID-19 lost seropositivity after 6 months. No reinfections were observed. These results may inform vaccination policies and clinical management of HM patients.
Collapse
Affiliation(s)
- C Cattaneo
- Hematology, ASST Spedali Civili, Brescia, Italy.
| | - V Cancelli
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - L Imberti
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - K Dobbs
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - A Sottini
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - C Pagani
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Belotti
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Re
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - A Anastasia
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - V Quaresima
- CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
| | - A Tucci
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - J A Chiorini
- National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA
| | - H C Su
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| | - J I Cohen
- Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD, USA
| | - P D Burbelo
- National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA
| | - G Rossi
- Hematology, ASST Spedali Civili, Brescia, Italy
| | - L D Notarangelo
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
18
|
Pezzulla D, Macchia G, Cilla S, Boccardi M, Re A, Bonome P, Picardi V, Ferro M, Romano C, Buwenge M, Cammelli S, Valentini V, Valenti V, Morganti A, Deodato F. PD-0887 VMAT Radiotherapy boost in oligometastatic patients with Spinal Metastases: a dose escalation study. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07166-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Bisello S, Arcelli A, Deodato F, Dominsky N, Tarantino G, Ntreta M, Cilla S, Siepe G, Cavallini L, Pezzulla D, Alitto A, Re A, Cammelli S, Cortesi A, Romeo A, Frezza G, Morganti A, Macchia G, Buwenge M. PO-1392 Salvage radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07843-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
20
|
Zamagni A, Bonetti M, Buwenge M, Ntreta M, Tolento G, Cammelli S, Donati C, Lodi Rizzini E, Boccardi M, Re A, Deodato F, Cilla S, Macchia G, Morganti A. PO-1394 Stereotactic body radiotherapy for prostate cancer lymph node metastases: a systematic review. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07845-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Bisello S, Arcelli A, Deodato F, Dominsky N, Tarantino G, Ntreta M, Cilla S, Siepe G, Cavallini L, Pezzulla D, Alitto A, Re A, Cammelli S, Cortesi A, Romeo A, Frezza G, Morganti A, Macchia G, Buwenge M. PO-1380 Adjuvant radiotherapy of prostate cancer: a risk stratification system based on prognostic factors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07831-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Tucci A, Musuraca G, Cavallo F, Zilioli VR, Zanni M, Pelliccia S, Mannina D, Michieli M, Vallisa D, Tani M, Merli F, Re F, Marcheselli L, Campostrini G, Pagani C, Grimaldi D, Liardo EV, Re A, Cox MC, Rossi G. AUTOLOGOUS TRANSPLANT IN ELDERLY PATIENTS WITH R/R AGGRESSIVE LYMPHOMA SELECTED BY SIMPLIFIED CGA: THE RECANZ PROSPECTIVE PHASE 2 STUDY BY THE FONDAZIONE ITALIANA LINFOMI. Hematol Oncol 2021. [DOI: 10.1002/hon.99_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A Tucci
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - G Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Hematology Unit Meldola (FC) Italy
| | - F Cavallo
- University of To‐rino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology, Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - V. R Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - M Zanni
- A.O. SS. Antonio e Biagio e Cesare Arrigo Division of Hematology Alessandria Italy
| | - S Pelliccia
- Hospital Sant’Andrea – Sapienza, Rome Hematology University Roma Italy
| | - D Mannina
- Azienda Ospedaliera Papardo Unit of Hematology Messina Italy
| | - M Michieli
- Aviano (PN) Haematology Transplant and Cell Therapy Unit Aviano (PN) Italy
| | - D Vallisa
- Ospedale Guglielmo da Saliceto Division of Hematology Piacenza Italy
| | - M Tani
- Ospedale delle Croci Department of Hematology Ravenna Italy
| | - F Merli
- Azienda Unità Sanitaria Locale – IRCCS Hematology Unit Reggio Emilia Italy
| | - F Re
- AOU di Parma Hematology Unit Parma Italy
| | - L Marcheselli
- Fondazione Italiana Linfomi Onlus Fondazione Italiana Linfomi Onlus Modena Italy
| | - G Campostrini
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - C Pagani
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - D Grimaldi
- University of To‐rino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology, Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - E. V Liardo
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Hematology Unit Meldola (FC) Italy
| | - A Re
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - M. C Cox
- University Hospital Sant’Andrea – Sapienza Hematology Roma Italy
| | - G Rossi
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| |
Collapse
|
23
|
Chiappella A, Carniti C, Re A, Castellino C, Evangelista A, Ciancia R, Orsucci L, Pinto A, Usai SV, Arcari A, Ilariucci F, Rossi FG, Benedetti F, Flenghi L, Ghiggi C, Molinari AL, Stefoni V, Volpetti S, Zilioli VR, Ballerini F, Bruna R, Cavallo F, Musuraca G, Patti C, Re F, Tani M, Varettoni M, Zanni M, Dodero A, Pileri SA, Ciccone G, Corradini P. ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN PERIPHERAL T‐CELL LYMPHOMA (PTCL): FIRST ANALYSIS OF THE PHASE II FIL‐PTCL13 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.130_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- A. Chiappella
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Hematology and Stem Cell Transplantation Milano Italy
| | - C. Carniti
- Fondazione IRCCS, Istituto Nazionale dei Tumori di Milano Laboratory of Hematology Division of Hematology and Stem Cell Transplantation Milano Italy
| | - A. Re
- ASST Spedali Civili di Brescia Hematology Division Brescia Italy
| | - C. Castellino
- Azienda Ospedaliera S. Croce e Carle Division of Hematology Cuneo Italy
| | - A. Evangelista
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza and CPO Piemonte Unit of Clinical Epidemiology Torino Italy
| | - R. Ciancia
- Centro di Riferimento Oncologico (CRO) IRCCS Onco‐hematology and Stem Cell Transplantation and Cellular Therapies Aviano Italy
| | - L. Orsucci
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza Division of Hematology Torino Italy
| | - A. Pinto
- Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS Hematology‐Oncology & Stem Cell Transplantation Unit Napoli Italy
| | - S. V. Usai
- Ospedale Oncologico Armando Businco Hematology Cagliari Italy
| | - A. Arcari
- Ospedale Guglielmo da Saliceto Hematology Unit Piacenza Italy
| | - F. Ilariucci
- Azienda USL‐IRCCS, Hematology Reggio Emilia Italy
| | - F. G. Rossi
- Fondazione IRCCS Cà Granda OM Policlinico Division of Hematology Milano Italy
| | - F. Benedetti
- Azienda Ospedaliera Universitaria di Verona Hematology and Stem Cell Transplantation Verona Italy
| | - L. Flenghi
- Azienda Ospedaliera di Perugia Hematology Perugia Italy
| | - C. Ghiggi
- IRCCS Ospedale Policlinico San Martino Hematology Genova Italy
| | | | - V. Stefoni
- University of Bologna Institute of Hematology "Seràgnoli" Bologna Italy
| | - S. Volpetti
- Presidio Ospedaliero Universitario "Santa Maria della Misericordia” di Udine ASUFC Clinic of Hematology Udine Italy
| | - V. R. Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - F. Ballerini
- IRCCS Ospedale Policlinico San Martino Clinic of Hematology Genova Italy
| | - R. Bruna
- Ospedale Maggiore Della Carità Division of Hematology Novara Italy
| | - F. Cavallo
- University of Torino Azienda Ospedaliera e Universitaria Città della Salute e della Scienza Division of Hematology Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - G. Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Division of Hematology Meldola Italy
| | - C. Patti
- Azienda Villa Sofia Cervello Division of Onco‐Hematology Palermo Italy
| | - F. Re
- Azienda Ospedaliera‐Universitaria di Parma Hematology and CTMO Parma Italy
| | - M. Tani
- Ospedale Santa Maria delle Croci Hematology Unit Ravenna Italy
| | - M. Varettoni
- Fondazione IRCCS Policlinico San Matteo Division of Hematology Pavia Italy
| | - M. Zanni
- Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo Division of Hematology Alessandria Italy
| | - A. Dodero
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Hematology and Stem Cell Transplantation Milano Italy
| | - S. A. Pileri
- European Institute of Oncology IRCCS Division of Haematopathology Milano Italy
| | - G. Ciccone
- Azienda Ospedaliera e Universitaria Città della Salute e della Scienza and CPO Piemonte Unit of Clinical Epidemiology Torino Italy
| | - P. Corradini
- Chair of Hematology University of Milano Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology and Stem Cell Transplantation Milano Italy
| |
Collapse
|
24
|
Tucci A, Merli F, Fabbri A, Mancuso S, Sartori R, Storti S, Luminari S, Mammi C, Marcheselli L, Arcari A, Cavallo F, Zilioli VR, Bottelli C, Re A, Gini G, Cox MC, Puccini B, Pagani C, Balzarotti M, Spina M, Rossi G. DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN LATE‐OCTOGENARIAN (LO) PATIENTS: A SUBSTUDY OF THE “ELDERLY PROJECT” BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.95_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A. Tucci
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - F. Merli
- Azienda Unità Sanitaria Locale – IRCCS Hematology Unit Reggio Emilia Italy
| | - A. Fabbri
- zienda Ospedaliera Universitaria Senese and University of Siena Unit of Hematology Siena Italy
| | - S. Mancuso
- Department Pro.Mi.Se Univeristy of Palermo Haematology Division Palermo Italy
| | - R. Sartori
- Veneto Institute of Oncology IOV‐IRCCS Department of Clinical and Experimental Oncology Oncohematology Unit Castelfranco Veneto (TV) Italy
| | - S. Storti
- Università Cattolica Onco‐hematology Unit Campobasso‐Roma Italy
| | - S. Luminari
- University of Modena and Reggio Emilia Azienda Unità Sanitaria Locale – IRCCS Department CHIMOMO Hematology Unit Reggio Emilia Italy
| | - C. Mammi
- Gruppo Amici dell'Ematologia GRADE‐ Onlus Foundation Hematology Unit Reggio Emilia Italy
| | - L. Marcheselli
- Fondazione Italiana Linfomi Onlus Fondazione Italiana Linfomi Onlus Modena Italy
| | - A. Arcari
- Ospedale Guglielmo da Saliceto Hematology Unit Piacenza Italy
| | - F. Cavallo
- University of Torino/AOU “Città della Salute e della Scienza di Torino” Division of Hematology Department of Molecular Biotechnologies and Health Sciences Torino Italy
| | - V. R. Zilioli
- ASST Grande Ospedale Metropolitano Niguarda Division of Hematology Milano Italy
| | - C. Bottelli
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - A. Re
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - G. Gini
- Azienda Ospedaliera Universitaria Ospedali Riuniti Division of Hematology Ancona Italy
| | - M. C. Cox
- Azienda Ospedaliera Universitaria S.Andrea Hematology Unit Roma Italy
| | - B. Puccini
- Careggi University Hospital Hematology Unit Firenze Italy
| | - C. Pagani
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| | - M. Balzarotti
- Humanitas Clinical Research Hospital‐IRCCS Department of Medical Oncology and Hematology Rozzano (MI) Italy
| | - M. Spina
- Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Division of Medical Oncology and Immune‐related Tumors Aviano (PN) Italy
| | - G. Rossi
- ASST Spedali Civili Brescia Hematology Division Brescia Italy
| |
Collapse
|
25
|
Merli F, Tucci A, Arcari A, Rigacci L, Cavallo F, Cabras G, Alvarez I, Fabbri A, Re A, Ferrero S, Puccini B, Usai SV, Ferrari A, Cencini E, Pennese E, Zilioli VR, Marino D, Balzarotti M, Cox MC, Zanni M, Rocco A, Lleshi A, Botto B, Hohaus S, Merli M, Sartori R, Gini G, Nassi L, Musuraca G, Tani M, Bottelli C, Kovalchuk S, Re F, Flenghi L, Molinari A, Tarantini G, Chimienti E, Marcheselli L, Mammi C, Luminari S, Spina M. THE ELDERLY PROGNOSTIC INDEX (EPI) PREDICTS EARLY MORTALITY IN OLDER PATIENTS WITH DLBCL. A SUBSTUDY OF THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.85_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
26
|
Cafiero C, Rosapepe F, Palmirotta R, Re A, Ottaiano MP, Benincasa G, Perone R, Varriale E, D'Amato G, Cacciamani A, Micera A, Pisconti S. Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study. Pharmgenomics Pers Med 2021; 14:621-629. [PMID: 34079337 PMCID: PMC8166347 DOI: 10.2147/pgpm.s303666] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 04/29/2021] [Indexed: 12/12/2022]
Abstract
Introduction The renin-angiotensin-aldosterone system (RAAS), a metabolic cascade regulating pressure and circulating blood volume, has been considered the main system involved in the pathogenesis of severe lung injury and organs decline in COVID-19 patients. The angiotensin I-converting enzyme (ACE1), angiotensin-converting enzyme 2 (ACE2), angiotensinogen (AGT) and receptors angiotensin II receptor type 1 (AGTR1) are key factors for SARS-CoV-2 entering in the cells, sodium and water retention with an increase blood pressure, promotion of fibrotic and inflammatory phenomena resulting in a cytokine storm. Methods In this pilot study, the frequencies of six polymorphisms in the ACE1, ACE2, AGT and AGTR1 genes were analysed in symptomatic patients affected by COVID-19 and compared with the results obtained from asymptomatic subjects. Results Thus, we have identified that rs2074192 (ACE2), rs1799752 (ACE1) and rs699 (AGT) SNPs could potentially be a valuable tool for predicting the clinical outcome of SARS-CoV-2 infected patients. A genetic predisposition may be prospected for severe internal organ damages and poor prognosis in patients with COVID-19 disease, as observed in symptomatic vs asymptomatic. Conclusion This study provides evidence that analysis of RAAS polymorphisms could be considered the key point in understanding and predicting the SARS-CoV-2 course infection.
Collapse
Affiliation(s)
| | - Felice Rosapepe
- Cardiothoracic Surgery Department, Pineta Grande Hospital, Castelvolturno, CE, Italy
| | - Raffaele Palmirotta
- Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy
| | - Agnese Re
- Catholic University of Sacred Heart, Rome, Italy
| | - Maria Pia Ottaiano
- Department of Molecular Medicine and Medical Biotechnology, University of Federico II, Naples, Italy
| | - Giulio Benincasa
- Department of Clinical Pathology and Molecular Biology, Pineta Grande Hospital, Castel Volturno, CE, Italy
| | - Romina Perone
- Anesthesiology Department, Pineta Grande Hospital, Castelvolturno, CE, Italy
| | | | - Gerardo D'Amato
- Endocrine and Metabolic Surgery, A Gemelli Polyclinic Foundation, Rome, Italy
| | - Andrea Cacciamani
- Research Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy
| | - Alessandra Micera
- Research Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy
| | | |
Collapse
|
27
|
Di Francia R, Crisci S, De Monaco A, Cafiero C, Re A, Iaccarino G, De Filippi R, Frigeri F, Corazzelli G, Micera A, Pinto A. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers. Cancers (Basel) 2021; 13:cancers13050966. [PMID: 33669053 PMCID: PMC7956511 DOI: 10.3390/cancers13050966] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2021] [Revised: 02/18/2021] [Accepted: 02/19/2021] [Indexed: 01/04/2023] Open
Abstract
Simple Summary In this review, the authors propose a crosswise examination of cytarabine-related issues ranging from the spectrum of clinical activity and severe toxicities, through updated cellular pharmacology and drug formulations, to the genetic variants associated with drug-induced phenotypes. Cytarabine (cytosine arabinoside; Ara-C) in multiagent chemotherapy regimens is often used for leukemia or lymphoma treatments, as well as neoplastic meningitis. Chemotherapy regimens can induce a suboptimal clinical outcome in a fraction of patients. The individual variability in clinical response to Leukemia & Lymphoma treatments among patients appears to be associated with intracellular accumulation of Ara-CTP due to genetic variants related to metabolic enzymes. The review provides exhaustive information on the effects of Ara-C-based therapies, the adverse drug reaction will also be provided including bone pain, ocular toxicity (corneal pain, keratoconjunctivitis, and blurred vision), maculopapular rash, and occasional chest pain. Evidence for predicting the response to cytarabine-based treatments will be highlighted, pointing at their significant impact on the routine management of blood cancers. Abstract Cytarabine is a pyrimidine nucleoside analog, commonly used in multiagent chemotherapy regimens for the treatment of leukemia and lymphoma, as well as for neoplastic meningitis. Ara-C-based chemotherapy regimens can induce a suboptimal clinical outcome in a fraction of patients. Several studies suggest that the individual variability in clinical response to Leukemia & Lymphoma treatments among patients, underlying either Ara-C mechanism resistance or toxicity, appears to be associated with the intracellular accumulation and retention of Ara-CTP due to genetic variants related to metabolic enzymes. Herein, we reported (a) the latest Pharmacogenomics biomarkers associated with the response to cytarabine and (b) the new drug formulations with optimized pharmacokinetics. The purpose of this review is to provide readers with detailed and comprehensive information on the effects of Ara-C-based therapies, from biological to clinical practice, maintaining high the interest of both researcher and clinical hematologist. This review could help clinicians in predicting the response to cytarabine-based treatments.
Collapse
Affiliation(s)
- Raffaele Di Francia
- Italian Association of Pharmacogenomics and Molecular Diagnostics, 60126 Ancona, Italy;
| | - Stefania Crisci
- Hematology-Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, 80131 Naples, Italy; (S.C.); (G.I.); (R.D.F.); (G.C.); (A.P.)
| | - Angela De Monaco
- Clinical Patology, ASL Napoli 2 Nord, “S.M. delle Grazie Hospital”, 80078 Pozzuoli, Italy;
| | - Concetta Cafiero
- Medical Oncology, S.G. Moscati, Statte, 74010 Taranto, Italy
- Correspondence: or (C.C.); (A.M.); Tel.:+39-34-0101-2002 (C.C.); +39-06-4554-1191 (A.M.)
| | - Agnese Re
- Università Cattolica del Sacro Cuore, 00168 Rome, Italy;
| | - Giancarla Iaccarino
- Hematology-Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, 80131 Naples, Italy; (S.C.); (G.I.); (R.D.F.); (G.C.); (A.P.)
| | - Rosaria De Filippi
- Hematology-Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, 80131 Naples, Italy; (S.C.); (G.I.); (R.D.F.); (G.C.); (A.P.)
- Department of Clinical Medicine and Surgery, Federico II University, 80131 Naples, Italy
| | | | - Gaetano Corazzelli
- Hematology-Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, 80131 Naples, Italy; (S.C.); (G.I.); (R.D.F.); (G.C.); (A.P.)
| | - Alessandra Micera
- Research and Development Laboratory for Biochemical, Molecular and Cellular Applications in Ophthalmological Sciences, IRCCS—Fondazione Bietti, 00184 Rome, Italy
- Correspondence: or (C.C.); (A.M.); Tel.:+39-34-0101-2002 (C.C.); +39-06-4554-1191 (A.M.)
| | - Antonio Pinto
- Hematology-Oncology and Stem Cell transplantation Unit, National Cancer Institute, Fondazione “G. Pascale” IRCCS, 80131 Naples, Italy; (S.C.); (G.I.); (R.D.F.); (G.C.); (A.P.)
| |
Collapse
|
28
|
Re A, Cilla S, Ferro M, Ianiro A, Macchia G, Picardi V, Boccardi M, Cammelli S, Romano C, D'Addario D, Buwenge M, Mignogna S, Ferro M, Valentini V, Sallustio G, Morganti A, Deodato F. PO-0794: Induction chemotherapy followed by moderately accelerated IMRT in head and neck cancer patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00811-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
29
|
Ferro M, Ianiro A, Re A, Macchia G, Cilla S, Picardi V, Boccardi M, Ferro M, Cammelli S, Romano C, Bisello S, Buwenge M, Mignogna S, Giglio G, Cucci E, Valentini V, Morganti A, Deodato F. OC-0091: SIB accelerated RT and concomitant TMZ in GBM patients: results of a phase I study (ISIDE BT-2). Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00117-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Alitto A, Buwenge M, Macchia G, Ntreta M, Siepe G, Galofaro E, Bertini F, Ferioli M, Mazzeo E, Ippolito E, Mantini G, Ferro M, Re A, Cilla S, Valentini V, Deodato F, Morganti A, Cammelli S. PO-1185: Results of prostate cancer patients treated by integrated boost to dominant intraprostatic lesion. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01203-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
31
|
Deodato F, Re A, Ianiro A, Ferro M, Macchia G, Picardi V, Boccardi M, Buwenge M, Assalone P, Berardinelli F, Maselli G, Cammelli S, Ferro M, Romano C, Mignogna S, Valentini V, Morganti A, Cilla S. PD-0667: Early analysis from two phase I trials on SBRT of isolated nodal recurrences in prostate patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00689-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Ferioli M, Panni V, Galuppi A, Zamagni A, Buwenge M, Macchia G, Deodato F, Re A, Boccardi M, Cilla S, Fanti S, Morganti A, Cammelli S. PO-1134: 18F-FDG-PET/CT role in the adjuvant setting of endometrial cancer. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01151-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Re A, Picardi V, Deodato F, Ianiro A, Cilla S, Boccardi M, Ferro M, Arcelli A, Buwenge M, Cammelli S, Romano C, Restaino G, Ferro M, Specchia M, Guido A, Mignogna S, Valentini V, Morganti A, Macchia G. PO-1083: Efficacy and tolerance of VMAT-SIB intensified neoadjuvant chemoradiation in rectal cancer patients. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01100-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
34
|
Macchia G, Cerrotta A, Deodato F, Pappalardi B, Re A, Santoni R, Campitelli M, Scambia G, Valentini V, Aristei C, Ferrandina G. PO-1116: Cervical cancer patterns of care in italy: a radiation oncology survey of mito and airo gyn groups. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)01133-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S. Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease. Pharmgenomics Pers Med 2020; 13:463-484. [PMID: 33116761 PMCID: PMC7568633 DOI: 10.2147/pgpm.s270069] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/12/2020] [Accepted: 09/09/2020] [Indexed: 12/11/2022]
Abstract
The latest developments in precision medicine allow the modulation of therapeutic approaches in different pathologies on the basis of the specific molecular characterization of the patient. This review of the literature coupled with in silico analysis was to provide a selected screening of interactions between single-nucleotide polymorphisms (SNPs) and drugs (repurposed, investigational, and biological agents) showing efficacy and toxicityin counteracting Covid-19 infection. In silico analysis of genetic variants related to each drug was performed on such databases as PharmGKB, Ensembl Genome Browser, www.drugs.com, and SNPedia, with an extensive literature review of papers (to May 10, 2020) on Covid-19 treatments using Medline, Embase, International Pharmaceutical Abstracts, PharmGKB, and Google Scholar. The clinical relevance of SNPs, known as both drug targets and markers, considering genetic variations with known drug responses, and the therapeutic consequences are discussed. In the context of clinical treatment of Covid-19, including infection prevention, control measures, and supportive care, this review highlights the importance of a personalized approach in the final selection of therapy, which is probably essential in the management of the Covid-19 pandemic.
Collapse
Affiliation(s)
| | - Agnese Re
- CNR-IASI, Catholic University of Sacred Heart, Rome, Italy
| | - Alessandra Micera
- Research Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy
| | - Raffaele Palmirotta
- Department of Biomedical Sciences and Clinical Oncology, Oncogenomic Research Center, Aldo Moro University of Bari, Bari, Italy
| | | | - Francesca Romano
- Department of Precision Medicine, Luigi Vanvitelli University of Campania, Napoli, Italy
| | | | - Raffaele Di Francia
- Italian Association of Pharmacogenomics and Molecular Diagnostics, Ancona, Italy
| | - Andrea Cacciamani
- Research Laboratories in Ophthalmology, IRCCS - Fondazione Bietti, Rome, Italy
| | - Pier Luigi Surico
- Oncology and Hematology Department, F Miulli Hospital, Acquaviva delle Fonti, Italy
| | - Gerardo D'Amato
- Endocrine and Metabolic Surgery, A Gemelli Polyclinic Foundation, Rome, Italy
| | | |
Collapse
|
36
|
Cafiero C, Re A, Pisconti S, Trombetti M, Perri M, Colosimo M, D’Amato G, Gallelli L, Cannataro R, Molinario C, Fazio A, Caroleo MC, Cione E. Dysbiosis in intestinal microbiome linked to fecal blood determined by direct hybridization. 3 Biotech 2020; 10:358. [PMID: 32821643 PMCID: PMC7387388 DOI: 10.1007/s13205-020-02351-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 07/21/2020] [Indexed: 02/06/2023] Open
Abstract
The important physiological and pathophysiological roles of intestinal human microbiome (HMB) in human health have been emerging, owing to the access to molecular biology techniques. Herein we evaluated, for the first time, the intestinal HMB through direct hybridization approach using n-counter flex DX technology which bypasses the amplification procedure currently applied by other technologies to study the human microbiome. To this purpose, a clinical study was carried out on fecal samples, recruiting both healthy volunteers (N-FOB) and subjects positive for occult blood (P-FOB). A relevant custom panel of 79 16S rRNA target gene was engineered and 32 of them displayed a variation between the two clusters of subjects. Our findings revealed that bacteria belonging to Proteobacteria have higher distribution in P-FOB describing dysbiosis. Similarly, Bacteroidetes and Firmicutes phylum display high distribution in P-FOB. Of interest, the presence of Clostridium difficile that belongs to Firmicutes phylum displayed about 70% of low presence in N-FOB compared to P-FOB subjects. Only one bacterium belonging to the Actinobacteria phylum, the Bifidobacterium bifidum, was present.
Collapse
Affiliation(s)
- Concetta Cafiero
- Oncology Unit, SG Moscati Hospital of Taranto, Taranto, Italy
- Laboratory of Medical Genetics, Alessandria Artemisia, Rome, Italy
| | - Agnese Re
- Laboratory of Medical Genetics, Alessandria Artemisia, Rome, Italy
- CNR-Institute of Cell Biology and Neurobiology, Rome, Italy
| | | | - Marina Trombetti
- Dietetics and Aesthetic Medicine Section, Alessandria Artemisia, Rome, Italy
| | - Mariarita Perri
- Department of Pharmacy, Health and Nutritional Sciences-Department of Excellence 2018-2022, University of Calabria, 87036 Rende, CS Italy
| | - Manuela Colosimo
- Department of Microbiology and Virology, Pugliese Ciaccio Hospital, Catanzaro, Italy
| | - Gerardo D’Amato
- Department of Endocrine and Metabolic Surgery, Policlinico Universitario A Gemelli-Università Cattolica del Sacro Cuore, Rome, Italy
- Department of Endocrine and Metabolic Surgery, Mater Olbia Hospital, Olbia, Italy
| | - Luca Gallelli
- Clinical Pharmacology and Pharmacovigilance Unit, Department of Health Sciences, Mater Domini Hospital, University of Catanzaro, Catanzaro, Italy
| | - Roberto Cannataro
- Department of Pharmacy, Health and Nutritional Sciences-Department of Excellence 2018-2022, University of Calabria, 87036 Rende, CS Italy
- Nutrics, Nutritional Center, Luzzi, CS Italy
| | - Clelia Molinario
- Laboratory of Medical Genetics, Alessandria Artemisia, Rome, Italy
| | - Alessia Fazio
- Department of Pharmacy, Health and Nutritional Sciences-Department of Excellence 2018-2022, University of Calabria, 87036 Rende, CS Italy
| | - Maria Cristina Caroleo
- Department of Pharmacy, Health and Nutritional Sciences-Department of Excellence 2018-2022, University of Calabria, 87036 Rende, CS Italy
| | - Erika Cione
- Department of Pharmacy, Health and Nutritional Sciences-Department of Excellence 2018-2022, University of Calabria, 87036 Rende, CS Italy
| |
Collapse
|
37
|
Aceto G, Re A, Mattera A, Leone L, Colussi C, Rinaudo M, Scala F, Gironi K, Barbati SA, Fusco S, Green T, Laezza F, D'Ascenzo M, Grassi C. GSK3β Modulates Timing-Dependent Long-Term Depression Through Direct Phosphorylation of Kv4.2 Channels. Cereb Cortex 2020; 29:1851-1865. [PMID: 29790931 DOI: 10.1093/cercor/bhy042] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 01/15/2018] [Accepted: 02/07/2018] [Indexed: 12/31/2022] Open
Abstract
Spike timing-dependent plasticity (STDP) is a form of activity-dependent remodeling of synaptic strength that underlies memory formation. Despite its key role in dictating learning rules in the brain circuits, the molecular mechanisms mediating STDP are still poorly understood. Here, we show that spike timing-dependent long-term depression (tLTD) and A-type K+ currents are modulated by pharmacological agents affecting the levels of active glycogen-synthase kinase 3 (GSK3) and by GSK3β knockdown in layer 2/3 of the mouse somatosensory cortex. Moreover, the blockade of A-type K+ currents mimics the effects of GSK3 up-regulation on tLTD and occludes further changes in synaptic strength. Pharmacological, immunohistochemical and biochemical experiments revealed that GSK3β influence over tLTD induction is mediated by direct phosphorylation at Ser-616 of the Kv4.2 subunit, a molecular determinant of A-type K+ currents. Collectively, these results identify the functional interaction between GSK3β and Kv4.2 channel as a novel mechanism for tLTD modulation providing exciting insight into the understanding of GSK3β role in synaptic plasticity.
Collapse
Affiliation(s)
- Giuseppe Aceto
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Agnese Re
- Institute of Cell Biology and Neurobiology, National Research Council, Rome, Italy
| | - Andrea Mattera
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Lucia Leone
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy
| | - Claudia Colussi
- Institute of Cell Biology and Neurobiology, National Research Council, Rome, Italy
| | - Marco Rinaudo
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Federico Scala
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA
| | - Katia Gironi
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | | | - Salvatore Fusco
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy
| | - Thomas Green
- Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Fernanda Laezza
- Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Marcello D'Ascenzo
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy
| | - Claudio Grassi
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy
| |
Collapse
|
38
|
Cafiero C, Re A, D'Amato G, Surico PL, Surico G, Pirrelli M, Pisconti S. KRAS and BRAF Concomitant Mutations in a Patient with Metastatic Colon Adenocarcinoma: An Interesting Case Report. Case Rep Oncol 2020; 13:595-600. [PMID: 32595468 PMCID: PMC7315173 DOI: 10.1159/000507882] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 04/10/2020] [Indexed: 12/29/2022] Open
Abstract
A 68-year-old female patient with tenesmus and blood in the stool was admitted to the S.G. Moscati Hospital of Taranto. Investigations revealed infiltrative mucinous colon adenocarcinoma accompanied by lymph node metastases. Following surgery and adjuvant chemotherapy, computed tomography (CT) and carcinoembryonic antigen screening were negative. Two years later, CT demonstrated a liver lesion. Histologic and genetic analyses confirmed the diagnosis of metastatic colorectal cancer with the coexistence of KRAS and BRAF mutations in hepatic metastases and the presence of the BRAF V600E in the primary tumour. It is unclear whether the lack of response was due to BRAF mutations, but the data suggest that mutated BRAF confers resistance to anti-epidermal growth factor receptor therapy. In our patient, BRAF mutation turned out to be a negative prognostic factor, and it may have been the cause of clinical implications for disease progression and therapeutic responses.
Collapse
Affiliation(s)
- Concetta Cafiero
- Unità di Oncologia Medica, Ospedale S.G. Moscati, Taranto, Italy
| | - Agnese Re
- Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI), Consiglio Nazionale delle Ricerche (CNR), Rome, Italy
| | - Gerardo D'Amato
- Dipartimento di Chirurgia, Fondazione Policlinico A. Gemelli, Rome, Italy
| | - Pier Luigi Surico
- Unità di Oncologia, Ente Ecclesiastico Miulli, Acquaviva delle Fonti, Italy
| | - Giammarco Surico
- Unità di Oncologia, Ente Ecclesiastico Miulli, Acquaviva delle Fonti, Italy
| | - Michele Pirrelli
- Unità di Anatomia Patologica, Ospedale SS Annunziata, Taranto, Italy
| | | |
Collapse
|
39
|
Nanni S, Bacci L, Aiello A, Re A, Salis C, Grassi C, Pontecorvi A, Gaetano C, Farsetti A. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer. Mol Cell Endocrinol 2020; 511:110864. [PMID: 32413384 DOI: 10.1016/j.mce.2020.110864] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Revised: 04/16/2020] [Accepted: 05/07/2020] [Indexed: 12/13/2022]
Abstract
Prostate cancer (PCa) is a sex-steroid hormone-dependent cancer in which estrogens play a critical role in both initiation and progression. Recently, several long non-coding RNAs (lncRNAs) have been associated with PCa and are supposedly playing a pivotal role in the biology and progression of this type of cancer. In this review, we focused on some lncRNAs that are known for their androgen and estrogen transcriptional responsiveness in PCa. Specifically, we summarized recent pieces of evidence about lncRNAs NEAT1, H19, MALAT1, and HOTAIR, in estrogen signaling, emphasizing their role in PCa progression and the acquisition of a castration-resistant phenotype. Here, the reader will find information about lncRNAs present in estrogen-dependent transcriptional complexes. The potential role of lncRNA/estrogen signaling as a novel pathway for PCa treatment will be discussed.
Collapse
Affiliation(s)
- Simona Nanni
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
| | - Lorenza Bacci
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168, Roma, Italy
| | - Aurora Aiello
- Institute for Systems Analysis and Computer Science "A. Ruberti" (IASI), National Research Council (CNR), 00185, Rome, Italy
| | - Agnese Re
- Institute for Systems Analysis and Computer Science "A. Ruberti" (IASI), National Research Council (CNR), 00185, Rome, Italy
| | - Chiara Salis
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168, Roma, Italy
| | - Claudio Grassi
- Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, 00168, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
| | - Alfredo Pontecorvi
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
| | - Carlo Gaetano
- Laboratorio di Epigenetica, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, Italy.
| | - Antonella Farsetti
- Institute for Systems Analysis and Computer Science "A. Ruberti" (IASI), National Research Council (CNR), 00185, Rome, Italy.
| |
Collapse
|
40
|
Agostini M, Altenmüller K, Appel S, Atroshchenko V, Bagdasarian Z, Basilico D, Bellini G, Benziger J, Bick D, Bravo D, Caccianiga B, Calaprice F, Caminata A, Cavalcante P, Chepurnov A, D’Angelo D, Davini S, Derbin A, Di Giacinto A, Di Marcello V, Ding X, Di Ludovico A, Di Noto L, Drachnev I, Formozov A, Franco D, Galbiati C, Gschwender M, Ghiano C, Giammarchi M, Goretti A, Gromov M, Guffanti D, Hagner C, Houdy T, Hungerford E, Ianni A, Ianni A, Jany A, Jeschke D, Kobychev V, Korga G, Kumaran S, Lachenmaier T, Laubenstein M, Litvinovich E, Lombardi P, Lomskaya I, Ludhova L, Lukyanchenko G, Lukyanchenko L, Machulin I, Marcocci S, Martyn J, Meroni E, Meyer M, Miramonti L, Misiaszek M, Muratova V, Neumair B, Nieslony M, Nugmanov R, Oberauer L, Orekhov V, Ortica F, Pallavicini M, Papp L, Penek Ö, Pietrofaccia L, Pilipenko N, Pocar A, Raikov G, Ranalli M, Ranucci G, Razeto A, Re A, Redchuk M, Romani A, Rossi N, Rottenanger S, Schönert S, Semenov D, Skorokhvatov M, Smirnov O, Sotnikov A, Suvorov Y, Tartaglia R, Testera G, Thurn J, Unzhakov E, Vishneva A, Vogelaar R, von Feilitzsch F, Wojcik M, Wurm M, Zavatarelli S, Zuber K, Zuzel G. Improved measurement of
B8
solar neutrinos with
1.5 kt·y
of Borexino exposure. Int J Clin Exp Med 2020. [DOI: 10.1103/physrevd.101.062001] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
41
|
Re A, Ferraù F, Cafiero C, Spagnolo F, Barresi V, Romeo DP, Ragonese M, Grassi C, Pontecorvi A, Farsetti A, Cannavò S. Somatic Deletion in Exon 10 of Aryl Hydrocarbon Receptor Gene in Human GH-Secreting Pituitary Tumors. Front Endocrinol (Lausanne) 2020; 11:591039. [PMID: 33281746 PMCID: PMC7689685 DOI: 10.3389/fendo.2020.591039] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Accepted: 10/12/2020] [Indexed: 12/14/2022] Open
Abstract
OBJECTIVE/PURPOSE The aryl hydrocarbon receptor (AHR) pathway plays a critical role in the biology of Growth Hormone (GH)-secreting pituitary tumor (somatotropinoma). Germline rs2066853 AHR variant was found to be more frequent among acromegaly patients and associated with a more severe disease with larger invasive somatropinoma, and with resistance to somatostatin analogs treatment in patients living in polluted areas. However, no somatic changes in AHR gene have been reported so far in acromegaly patients. On that basis, the aim of the study was to assess at the somatic level the AHR gene status encompassing exon 10 region, also because of the high rate of variants found in this genomic region. METHODS A cohort of 13 patients aged 20-76 years with biochemical, clinical and histological diagnosis of somatotropinoma was studied. DNA and RNA from pituitary tumor histological samples have been extracted and analyzed by PCR and direct sequencing for AHR gene variants, and compared with corresponding patients' germline DNA as well as normal pituitary tissue as reference control. RESULTS A degenerated letter codes in the region corresponding to AHR exon 10 (c.1239-c.2056) was detected in somatotropinomas-derived DNA but not in that of matched germline and pituitary normal tissue. By multiple PCR and sequencing analysis, we observed amplification only before codon 1246 and after codon 1254, confirming the presence of a tumor-restricted somatic deletion in the 5' upstream region of AHR exon 10. Analysis of PCR-amplified cDNA revealed a wildtype sequence of exon 9 and 10 in normal pituitary tissue, and a wildtype sequence of exon 9 and 10 up to codon 1246 and no sequence after the deletion region (c.1246-c.1254) in 6 out of 9 tumor samples. Patients carrying the germline rs2066853 AHR variant showed no somatic LOH at the corresponding genetic locus. CONCLUSION This is the first demonstration of a recurrent somatic deletion in the exon 10 of the AHR gene in somatotropinomas. The functional impact of this genetic finding needs to be clarified.
Collapse
Affiliation(s)
- Agnese Re
- Institute for Systems Analysis and Computer Science “A. Ruberti” (IASI), National Research Council (CNR), Rome, Italy
- *Correspondence: Salvatore Cannavò, ; Agnese Re,
| | - Francesco Ferraù
- Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy
- Endocrine Unit, University Hospital G. Martino, Messina, Italy
| | | | | | - Valeria Barresi
- Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy
| | | | - Marta Ragonese
- Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy
| | - Claudio Grassi
- Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - Alfredo Pontecorvi
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Antonella Farsetti
- Institute for Systems Analysis and Computer Science “A. Ruberti” (IASI), National Research Council (CNR), Rome, Italy
| | - Salvatore Cannavò
- Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy
- Endocrine Unit, University Hospital G. Martino, Messina, Italy
- *Correspondence: Salvatore Cannavò, ; Agnese Re,
| |
Collapse
|
42
|
Grippaudo C, Cafiero C, D'Apolito I, Re A, Genuardi M, Chiurazzi P, Frazier-Bowers SA. A novel nonsense PTH1R variant shows incomplete penetrance of primary failure of eruption: a case report. BMC Oral Health 2019; 19:249. [PMID: 31730001 PMCID: PMC6858648 DOI: 10.1186/s12903-019-0944-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Accepted: 10/31/2019] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Aim of this work was to describe a rare inheritance pattern of Primary Failure of Eruption (PFE) in a small family with incomplete penetrance of PFE and a novel nonsense PTH1R variant. CASE PRESENTATION The proband, a 26 year-old man with a significant bilateral open-bite, was diagnosed with PFE using clinical and radiographic characteristics. DNA was extracted from the proband and his immediate family using buccal swabs and the entire PTH1R coding sequence was analyzed, revealing a novel heterozygous nonsense variant in exon 7 of PTH1R (c.505G > T). This variant introduces a premature stop codon in position 169, predicted to result in the production of a truncated and non-functional protein. This variant has never been reported in association with PFE and is not present in the Genome Aggregation Database (gnomAD). Interestingly, the c.505G > T variant has also been identified in the unaffected mother of our proband, suggesting incomplete penetrance of PFE. CONCLUSIONS In this study, we report a new PTH1R variant that segregates in an autosomal dominant pattern and causes PFE with incomplete penetrance. This underlines the diagnostic value of a thorough clinical and genetic analysis of all family members in order to estimate accurate recurrence risks, identify subtle clinical manifestations and provide proper management of PFE patients.
Collapse
Affiliation(s)
- Cristina Grippaudo
- Istituto di Clinica Odontoiatrica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Roma, Italy.
| | - Concetta Cafiero
- Istituto di Clinica Odontoiatrica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Roma, Italy
| | - Isabella D'Apolito
- Istituto di Clinica Odontoiatrica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Roma, Italy
| | - Agnese Re
- Istituto di Fisiologia Umana, Università Cattolica del Sacro Cuore, Roma, Italy.,Istituto di Biologia Cellulare e Neurobiologia, Consiglio Nazionale delle Ricerche (CNR), Roma, Italy
| | - Maurizio Genuardi
- Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Roma, Italy
| | - Pietro Chiurazzi
- Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Roma, Italy
| | - Sylvia A Frazier-Bowers
- Department of Orthodontics, School of Dentistry, University of North Carolina, Chapel Hill, NC, USA
| |
Collapse
|
43
|
Rusconi C, Tucker D, Bernard S, Muzi C, Crucitti L, Stefani P, Cox M, Gini G, Re A, Sciarra R, Liberati A, Morello L, Arcari A, Mannina D, Vitagliano O, Sartori R, Chiappella A, Balzarotti M, Vitolo U, Thieblemont C, Rule S, Visco C. IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.54_2630] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- C. Rusconi
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - D. Tucker
- Department of Haematology; Royal Cornwall NHSTrust; Truro Cornwall United Kingdom
| | - S. Bernard
- Service d'Onco-Hématologie; Hôpital Saint-Louis, AP-HP; Paris France
| | - C. Muzi
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - L. Crucitti
- Division of Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milan Italy
| | - P. Stefani
- U.O.C. di Ematologia; Dipartimento di Medicina Specialistica, Unità Locale Socio-Sanitaria della Marca Trevigiana; Treviso Italy
| | - M. Cox
- Haematology Unit, Department of Clinical and Experimental Medicine; Sapienza University, AO Sant'Andrea; Rome Italy
| | - G. Gini
- Division of Hematology; Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona; Ancona Italy
| | - A. Re
- U.O. Ematologia; Spedali Civili di Brescia; Brescia Italy
| | - R. Sciarra
- Division of Hematology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - A. Liberati
- Università di Perugia; AO Santa Maria di Terni; Terni Italy
| | - L. Morello
- Department of Medica Oncology and Hematology; Humanitas Clinical and Research Center - IRCCS; Rozzano Milan Italy
| | - A. Arcari
- Hematology Unit; Ospedale Guglielmo da Saliceto; Piacenza Italy
| | - D. Mannina
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - O. Vitagliano
- Division of Hematology; Cardarelli Hospital; Naples Italy
| | - R. Sartori
- Hematology Department; Castelfranco Veneto Hospital, ULSS 2 Marca Trevigiana, Castelfranco Veneto; Treviso Italy
| | - A. Chiappella
- Hematology; AO Città della Salute e della Scienza di Torino; Turin Italy
| | - M. Balzarotti
- Department of Medica Oncology and Hematology; Humanitas Clinical and Research Center - IRCCS; Rozzano Milan Italy
| | - U. Vitolo
- Hematology; AO Città della Salute e della Scienza di Torino; Turin Italy
| | - C. Thieblemont
- Service d'Onco-Hématologie; Hôpital Saint-Louis, AP-HP; Paris France
| | - S. Rule
- Plymouth University; Peninsula Schools of Medicine ad Dentistry; Plymouth United Kingdom
| | - C. Visco
- Department of Medicine; Section of Hematology, University of Verona; Verona Italy
| |
Collapse
|
44
|
Chiappella A, Carniti C, Evangelista A, Re A, Cabras M, Stefoni V, Castellino C, Congiu A, Pinto A, Zanni M, Rusconi C, Molinari A, Ciancia R, Baldini L, Nassi L, Re F, Tani M, Ilariucci F, Cavallo F, Santoro A, Volpetti S, Dodero A, Pileri S, Ciccone G, Corradini P. PHASE II FIL-PTCL13 STUDY OF ROMIDEPSIN-CHOEP FOLLOWED BY HIGH-DOSE CHEMOTHERAPY AND TRANSPLANTATION IN UNTREATED PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2019. [DOI: 10.1002/hon.3_2632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A. Chiappella
- Ematologia; AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - C. Carniti
- Ematologia; Università degli Studi di Milano; Milano Italy
| | - A. Evangelista
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - A. Re
- Ematologia; ASTT Spedali Civili di Brescia; Brescia Italy
| | - M.G. Cabras
- Ematologia; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - V. Stefoni
- Ematologia; Policlinico S.Orsola-Malpighi, Istituto di Ematologia "Seragnoli"; Bologna Italy
| | - C. Castellino
- Ematologia e Trapianto di Midollo Osseo; AO Santa Croce e Carle; Cuneo Italy
| | - A.G. Congiu
- Ematologia; Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia; Genova Italy
| | - A. Pinto
- Ematologia Oncologica; Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale; Napoli Italy
| | - M. Zanni
- Ematologia; AO SS Antonio e Biagio e Cesare Arrigo; Alessandria Italy
| | - C. Rusconi
- Ematologia; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | | | - R. Ciancia
- Oncoematologia; trapianti emopoietici e terapie cellulari, Centro di Riferimento Oncologico CRO, IRCCS; Aviano Italy
| | - L. Baldini
- Ematologia; Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda; Milano Italy
| | - L. Nassi
- Ematologia; AOU Maggiore della Carità di Novara; Novara Italy
| | - F. Re
- Ematologia e CTMO; AOU Ospedale Maggiore di Parma; Parma Italy
| | - M. Tani
- Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
| | - F. Ilariucci
- Ematologia; Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS; Reggio Emilia Italy
| | - F. Cavallo
- Ematologia; Università degli Studi - AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Santoro
- Ematologia; Istituto Clinico Humanitas; Rozzano Italy
| | - S. Volpetti
- Ematologia; ASUI Santa Maria della Misericordia; Udine Italy
| | - A. Dodero
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy
| | - S.A. Pileri
- Emopatologia; Istituto Europeo Oncologico IRCCS; Milano Italy
| | - G. Ciccone
- SSD Epidemiologia Clinica e Valutativa; Clinical Trial Center, AOU Città della Salute e della Scienza di Torino e CPO Piemonte; Torino Italy
| | - P. Corradini
- Ematologia; Fondazione IRCCS Istituto Nazionale dei Tumori - Università degli Studi di Milano; Milano Italy
| |
Collapse
|
45
|
Ferreri A, Sassone M, Angelillo P, Zaja F, Re A, Spina M, Di Rocco A, Fabbri A, Stelitano C, Frezzato M, Rusconi C, Zambello R, Arcari A, Bertoldero G, De Lorenzo D, Volpetti S, Calimeri T, Perrone S, Cecchetti C, Ciceri F, Ponzoni M. LONG-TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT). Hematol Oncol 2019. [DOI: 10.1002/hon.65_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A.J. Ferreri
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - M.C. Sassone
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - P. Angelillo
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - F. Zaja
- SC Ematologia; Azienda Sanitaria Universitaria Integrata; Trieste Italy
| | - A. Re
- Division of Hematology; Spedali Civili; Brescia Italy
| | - M. Spina
- Oncologia; Centro di Riferimento Oncologico; Aviano Italy
| | - A. Di Rocco
- Division of Hematology; University ”La Sapienza”; Rome Italy
| | - A. Fabbri
- Division of Hematology; Azienda Ospedaliera Università Senese; Siena Italy
| | - C. Stelitano
- Division of Hematology; Azienda Ospedaliera Bianchi-Melacrino-Morelli; Reggio Calabria Italy
| | - M. Frezzato
- Division of Hematology; San Bortolo Hospital; Vicenza Italy
| | - C. Rusconi
- Division of Hematology; Niguarda Hospital; Milan Italy
| | - R. Zambello
- Division of Hematology; Azienda Ospedaliera di Padua; Padua Italy
| | - A. Arcari
- Department of Oncology and Hematology; Guglielmo da Saliceto Hospital; Piacenza Italy
| | - G. Bertoldero
- U.O. di Oncologia ed Ematologia Oncologica; Ospedale di Mirano; Mirano Italy
| | - D. De Lorenzo
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - S. Volpetti
- Clinica Ematologia; Azienda Sanitaria Universitaria Integrata, DAME; Udine Italy
| | - T. Calimeri
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - S. Perrone
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - C. Cecchetti
- Lymphoma Unit; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - F. Ciceri
- Onco-Hematology; IRCCS San Raffaele Scientific Institute; Milan Italy
| | - M. Ponzoni
- Pathology; IRCCS San Raffaele Scientific Institute; Milan Italy
| |
Collapse
|
46
|
Visco C, Di Rocco A, Tisi M, Morello L, Evangelista A, Zilioli V, Rusconi C, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Marin-Niebla A, McCulloch R, Gini G, Perrone T, Nassi L, Pennese E, Stefani P, Cox M, Bozzoli V, Fabbri A, Polli V, Ferrero S, De Celis I, Sica A, Arcaini L, Balzarotti M, Rule S, Vitolo U. OUTCOMES IN FIRST RELAPSED-REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE-FIRST STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.16_2629] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- C. Visco
- Medicine, Section of Hematology; University of Verona; Verona Italy
| | - A. Di Rocco
- Translational and Precision Medicine; Sapienza University of Rome; Rome Italy
| | - M.C. Tisi
- Medicine, Section of Hematology; University of Verona; Verona Italy
| | - L. Morello
- Hematology; Humanitas Clinical and Research Center; Rozzano Italy
| | - A. Evangelista
- Clinical Epidemiology; Città della Salute e della Scienza and CPO Piemonte; Torino Italy
| | - V.R. Zilioli
- Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - C. Rusconi
- Hematology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - S. Hohaus
- Institute of Hematology, Policlinico Gemelli Foundation; Catholic University of the Sacred Heart; Roma Italy
| | - R. Sciarra
- Haematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - A. Re
- Hematology; Spedali Civili; Brescia Italy
| | - C. Tecchio
- Medicine, Section of Hematology and Bone Marrow Transplant; University of Verona; Verona Italy
| | - A. Chiappella
- Hematology; Città della salute e della scienza University Hospital; Torino Italy
| | - A. Marin-Niebla
- Hematology; Vall d'Hebron Institut d'Oncologia (VHIO); Barcelona Spain
| | - R. McCulloch
- Haematology; University of Plymouth and Derriford Hospital; Plymouth United Kingdom
| | - G. Gini
- Hematology, Department of Clinical and Molecular Sciences; Marche Polytechnic University; Ancona Italy
| | - T. Perrone
- Hematology; University of Bari; Bari Italy
| | - L. Nassi
- Hematology; Azienda Ospedaliero-Universitaria Maggiore della Carità; Novara Italy
| | - E. Pennese
- Hematology; UOSD "Centro Diagnosi e Terapia dei Linfomi"; PO Santo Spirito Pescara Italy
| | - P.M. Stefani
- Hematology; Ca' Foncello Hospital; Treviso Italy
| | - M.C. Cox
- Hematology; AOU Sant'Andrea; Rome Italy
| | | | - A. Fabbri
- Hematology; Azienda Ospedaliera Universitaria Senese & University of Siena; Siena Italy
| | - V. Polli
- Hematology; Ospedale degli Infermi; Rimini Italy
| | - S. Ferrero
- Molecular Biotechnologies and Health Sciences; University of Torino/AOU "Città della Salute e della Scienza di Torino"; Torino Italy
| | - I.A. De Celis
- Hematology; AUSLL/IRCCS Santa Maria Nuova Hospital; Reggio Emilia Italy
| | - A. Sica
- Hematology; Policlinico di Napoli; Napoli Italy
| | - L. Arcaini
- Haematology Oncology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - M. Balzarotti
- Hematology; Humanitas Clinical and Research Center; Rozzano Italy
| | - S. Rule
- Haematology; University of Plymouth and Derriford Hospital; Plymouth United Kingdom
| | - U. Vitolo
- Hematology; Città della salute e della scienza University Hospital; Torino Italy
| |
Collapse
|
47
|
Stefoni V, Broccoli A, Botto B, Corradini P, Pinto A, Re A, Vitolo U, Fanti S, Argnani L, Zinzani P. FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS. Hematol Oncol 2019. [DOI: 10.1002/hon.105_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- V. Stefoni
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - A. Broccoli
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - B. Botto
- Hematology; Department of Oncology, University Hospital Città della Salute e della Scienza; Turin Italy
| | - P. Corradini
- IRCCS Istituto Nazionale dei Tumori; University of Milano; Milan Italy
| | - A. Pinto
- Hematology-Oncology and Stem Cell Transplantation Unit; National Cancer Institute, Fondazione Pascale; Naples Italy
| | - A. Re
- Hematology; Azienda socio-sanitaria territoriale, Ospedali Civili di Brescia; Brescia Italy
| | - U. Vitolo
- Hematology; Department of Oncology, University Hospital Città della Salute e della Scienza; Turin Italy
| | - S. Fanti
- Nuclear Medicine; Medicina Nucleare Metropolitana, Sant'Orsola-Malpighi Hospital, University of Bologna; Bologna Italy
| | - L. Argnani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| | - P. Zinzani
- Institute of Hematology “L. e A. Seràgnoli”; University of Bologna; Bologna Italy
| |
Collapse
|
48
|
Cafiero C, Re A, Stigliano E, Bassotti E, Moroni R, Grippaudo C. Optimization of DNA extraction from dental remains. Electrophoresis 2019; 40:1820-1823. [PMID: 31111969 PMCID: PMC6771583 DOI: 10.1002/elps.201900142] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2018] [Revised: 05/16/2019] [Accepted: 05/17/2019] [Indexed: 12/18/2022]
Abstract
Efficient DNA extraction procedures is a critical step involved in the process of successful DNA analysis of such samples. Various protocols have been devised for the genomic DNA extraction from human tissues and forensic stains, such as dental tissue that is the skeletal part that better preserves DNA over time. However DNA recovery is low and protocols require labor‐intensive and time‐consuming step prior to isolating genetic material. Herein, we describe an extremely fast procedure of DNA extraction from teeth compared to classical method. Sixteen teeth of 100‐year‐old human remains were divided into two groups of 8 teeth and we compared DNA yield, in term of quantity and quality, starting from two different sample preparation steps. Specifically, teeth of group 1 were treated with a classic technique based on several steps of pulverization and decalcification, while teeth of group 2 were processed following a new procedure to withdraw dental pulp. In the next phase, the samples of both group underwent the same procedure of extraction, quantification and DNA profile analysis. Our findings provide an alternative protocol to obtain a higher amount of good quality DNA in a fast time procedure, helpful for forensic and anthropological studies.
Collapse
Affiliation(s)
- Concetta Cafiero
- Università Cattolica del Sacro Cuore-Dental Institute, Rome, Italy
| | - Agnese Re
- Università Cattolica del Sacro Cuore-Dental Institute, Rome, Italy
| | - Egidio Stigliano
- Università Cattolica del Sacro Cuore-Institute of Pathological Anatomy, Rome, Italy
| | - Ezio Bassotti
- Università Cattolica del Sacro Cuore-Dental Institute, Rome, Italy
| | - Rossana Moroni
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
| | - Cristina Grippaudo
- Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.,Università Cattolica del Sacro Cuore, Rome, Italy
| |
Collapse
|
49
|
Re A, Chiloiro G, Boldrini L, Cellini F, Giraffa M, De Franco P, Corvari B, Meldolesi E, Fionda B, Cusumano D, Teodoli S, Valentini V, Gambacorta M. EP-1470 Response assessment in rectal cancer patients treated with MRI-guided RT: preliminary results. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31890-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Aceto G, Re A, Mattera A, Leone L, Colussi C, Rinaudo M, Scala F, Gironi K, Barbati SA, Fusco S, Green T, Laezza F, D'Ascenzo M, Grassi C. Corrigendum: GSK3β Modulates Timing-Dependent Long-Term Depression Through Direct Phosphorylation of Kv4.2 Channels. Cereb Cortex 2019; 29:5315. [PMID: 30806456 DOI: 10.1093/cercor/bhz028] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Indexed: 11/14/2022] Open
Affiliation(s)
- Giuseppe Aceto
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Agnese Re
- Institute of Cell Biology and Neurobiology, National Research Council, Rome, Italy
| | - Andrea Mattera
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Lucia Leone
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
| | - Claudia Colussi
- Institute of Cell Biology and Neurobiology, National Research Council, Rome, Italy
| | - Marco Rinaudo
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Federico Scala
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA
| | - Katia Gironi
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy
| | | | - Salvatore Fusco
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
| | - Thomas Green
- Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Fernanda Laezza
- Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA
| | - Marcello D'Ascenzo
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
| | - Claudio Grassi
- Institute of Human Physiology, Università Cattolica del Sacro Cuore, Rome, Italy.,Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
| |
Collapse
|